Literature DB >> 28533318

Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.

Jennifer Davis1.   

Abstract

Entities:  

Keywords:  Editorials; activating transcription factor 3; cardiac remodeling; fibrosis; hypertrophy; p38 mitogen-activated protein kinases

Mesh:

Substances:

Year:  2017        PMID: 28533318      PMCID: PMC6935562          DOI: 10.1161/CIRCULATIONAHA.117.028020

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  12 in total

1.  ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.

Authors:  Roy Kalfon; Lilach Koren; Sharon Aviram; Ortal Schwartz; Tsonwin Hai; Ami Aronheim
Journal:  Cardiovasc Res       Date:  2016-11-07       Impact factor: 10.787

2.  The regulation of ATF3 gene expression by mitogen-activated protein kinases.

Authors:  Dan Lu; Jingchun Chen; Tsonwin Hai
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo.

Authors:  Jennifer Davis; Adam R Burr; Gregory F Davis; Lutz Birnbaumer; Jeffery D Molkentin
Journal:  Dev Cell       Date:  2012-09-27       Impact factor: 12.270

4.  Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction.

Authors:  Y Okamoto; A Chaves; J Chen; R Kelley; K Jones; H G Weed; K L Gardner; L Gangi; M Yamaguchi; W Klomkleaw; T Nakayama; R L Hamlin; C Carnes; R Altschuld; J Bauer; T Hai
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 5.  ATF3 transcription factor and its emerging roles in immunity and cancer.

Authors:  Matthew R Thompson; Dakang Xu; Bryan R G Williams
Journal:  J Mol Med (Berl)       Date:  2009-08-25       Impact factor: 4.599

Review 6.  Myofibroblasts: trust your heart and let fate decide.

Authors:  Jennifer Davis; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2013-11-02       Impact factor: 5.000

7.  Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.

Authors:  Heng Zhou; Di-Fei Shen; Zhou-Yan Bian; Jing Zong; Wei Deng; Yan Zhang; Yuan-Yuan Guo; Hongliang Li; Qi-Zhu Tang
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

Review 8.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

9.  Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy.

Authors:  Lilach Koren; Ofer Elhanani; Izhak Kehat; Tsonwin Hai; Ami Aronheim
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

10.  MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response.

Authors:  Jennifer Davis; Nathan Salomonis; Natasha Ghearing; Suh-Chin J Lin; Jennifer Q Kwong; Apoorva Mohan; Maurice S Swanson; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2015-12-16       Impact factor: 14.919

View more
  1 in total

1.  PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice.

Authors:  Yu-Wen Cheng; Ze-Bei Zhang; Bei-Di Lan; Jing-Rong Lin; Xiao-Hui Chen; Ling-Ran Kong; Lian Xu; Cheng-Chao Ruan; Ping-Jin Gao
Journal:  J Exp Med       Date:  2021-07-08       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.